<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5774">
  <stage>Registered</stage>
  <submitdate>26/01/2015</submitdate>
  <approvaldate>26/01/2015</approvaldate>
  <nctid>NCT02353182</nctid>
  <trial_identification>
    <studytitle>The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.</studytitle>
    <scientifictitle>An Open Label Pilot Study of Feasibility of a Dexmedetomidine-Remifentanil-Caudal Anaesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The TREX Pilot Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>35014</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Surgical Procedures, Operative</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Dexmedetomidine
Treatment: drugs - Remifentanil
Treatment: drugs - Bupivacaine
Treatment: drugs - Ropivacaine

Experimental: Active open label single arm - Dexmedetomidine- remifentanil- caudal based anaesthetic for lower abdominal/lower extremity surgery.
Dexmedetomidine (Precedex): loading dose: 1 mcg/kg over 10 minutes. Infusion: Start 1 mcg/kg/hr; titrate up or down within 50% of starting doses as needed
Remifentanil (Ultiva): loading dose: 1 mcg/kg over 1-2 minutes. Infusion: Start at 0.2 mcg/kg/min. Titrate up or down (max 0.5 mcg/kg/min) as needed
Caudal- Bupivacaine (Marcaine) 0.175%-0.25% or Ropivacaine (Naropin) 0.2% with dose at discretion of anaesthetist


Treatment: drugs: Dexmedetomidine
Loading dose:1 mcg/kg over 10 minutes. Infusion: Start 1-1.5 mcg/kg/hr. Titrate up or down within 50% of starting doses as needed.

Treatment: drugs: Remifentanil
Loading dose: 1 mcg/kg over 1-2 minutes. Infusion: Start at 0.2-0.5 mcg/kg/min. Titrate up or down (max 0.5 mcg/kg/min) as needed.

Treatment: drugs: Bupivacaine
Administered in caudal/epidural/field block: 0.175%-0.25% (dose at discretion of anaesthetist)

Treatment: drugs: Ropivacaine
Administered in caudal/epidural/field block: 0.2% (dose at discretion of anaesthetist)

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of participants who need for intervention for light anaesthesia - Rescue treatment for light anaesthesia will be given if hypertension MAP &gt; 80 mmHg (confirmed with repeated measure) and/or patient movement.</outcome>
      <timepoint>120 minutes (duration of surgery)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants who need for intervention for haemodynamic changes - Rescue treatment for mild Hypotension will be given if MAP is between 40 mmHg and &lt;50 mmHg (confirmed with repeated measure)
Moderate Hypotension will be defined as MAP &lt;40 mmHg
Mild bradycardia will be defined as HR &lt;100 bpm for over one minute
Significant bradycardia will be defined as &lt;70 bpm over one minute</outcome>
      <timepoint>120 minutes (duration of surgery)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to recovery after anaesthesia</outcome>
      <timepoint>Time from last dressing to: eye opening, removal of airway device, first feed, and a modified Aldrete Score of 9-10 (average 30 minutes-4 hours)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants who have respiratory complications - Any episode of coughing, oxygen desaturation &lt;90%, breath holding &gt; 15 seconds</outcome>
      <timepoint>Start of anaesthesia until discharge from PACU (average 1-4 hours)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants who have pain after anaesthesia - FLACC (Face, Legs, Activity, Cry, Consolability) scale. The scale is scored in a range of 0-10 with 0 representing no pain.</outcome>
      <timepoint>End of surgery until discharge from PACU ( average 1-4 hours)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of participants who require rescue analgesia in PACU - Analgesia: morphine 0.025-0.05 mg/kg IV for analgesia; repeat 20 minutes. Analgesia thereafter as per local protocol</outcome>
      <timepoint>End of surgery until discharge from PACU (average 1-4 hours)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Infants aged 1 to 12 months (corrected age)

          -  ASA I or II

          -  Infants undergoing lower abdominal/lower extremity surgery anticipated to be &gt; 120
             minutes in duration

          -  Surgery requires caudal regional nerve block</inclusivecriteria>
    <inclusiveminage>1</inclusiveminage>
    <inclusiveminagetype>Month</inclusiveminagetype>
    <inclusivemaxage>12</inclusivemaxage>
    <inclusivemaxagetype>Months</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  ASA III or higher

          -  Any contraindication to caudal analgesia

          -  Any contraindication to an inhalational induction with sevoflurane

          -  Allergies to any medication in study protocol

          -  Planned admission to an ICU postoperatively (except level II or III neonatal ICU)

          -  Planned tracheal intubation postoperatively

          -  Mechanical ventilation postoperatively</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>60</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/09/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Royal Children's Hospital - Parkville</hospital>
    <postcode>3052 - Parkville</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oregon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state>Singapore</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Murdoch Childrens Research Institute</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Texas Children's Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Boston Childrenâ€™s Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Oregon Health and Science University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The Royal Children's Hospital Melbourne</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>UMC Utrecht</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Children's Hospital Medical Center, Cincinnati</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Children's Hospital of Philadelphia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Sydney Children's Hospitals Network</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The Cleveland Clinic</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Princess Margaret Hospital for Children</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University Hospital, Geneva</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Starship Children's Health</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Texas Southwestern Medical Center</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Gaslini Children's Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>KK Women's and Children's Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Animal studies suggest general anaesthetics harm the developing brain. It is unclear if these
      findings are relevant to humans but the issue has become a major concern. Recent data have
      found that monkeys exposed to anaesthesia as infants grow up to have slower learning than
      those not exposed.

      The aim of the TREX pilot study is to determine the feasibility of an alternative anaesthetic
      regimen for lower abdominal/lower extremity surgery in infants 1-12 months of age.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02353182</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrew J Davidson, MD</name>
      <address>Murdoch Childrens Research Institute</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>